Xeriant Stock Performance

XERI Stock  USD 0.01  0.0003  3.33%   
Xeriant holds a performance score of 6 on a scale of zero to a hundred. The firm maintains a market beta of -2.1, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Xeriant are expected to decrease by larger amounts. On the other hand, during market turmoil, Xeriant is expected to outperform it. Use Xeriant sortino ratio, downside variance, as well as the relationship between the Downside Variance and rate of daily change , to analyze future returns on Xeriant.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Xeriant are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Xeriant demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow962.5 K
Total Cashflows From Investing Activities-135.3 K
  

Xeriant Relative Risk vs. Return Landscape

If you would invest  0.70  in Xeriant on November 14, 2025 and sell it today you would earn a total of  0.17  from holding Xeriant or generate 24.29% return on investment over 90 days. Xeriant is currently generating 1.0983% in daily expected returns and assumes 12.8871% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Xeriant, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Xeriant is expected to generate 16.36 times more return on investment than the market. However, the company is 16.36 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 per unit of risk.

Xeriant Target Price Odds to finish over Current Price

The tendency of Xeriant OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 65.99
Based on a normal probability distribution, the odds of Xeriant to move above the current price in 90 days from now is about 65.99 (This Xeriant probability density function shows the probability of Xeriant OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Xeriant has a beta of -2.1. This entails as returns on its benchmark rise, returns on holding Xeriant are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Xeriant is expected to outperform its benchmark. Additionally Xeriant has an alpha of 0.7338, implying that it can generate a 0.73 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Xeriant Price Density   
       Price  

Predictive Modules for Xeriant

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xeriant. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0113.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.0113.01
Details

Xeriant Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Xeriant is not an exception. The market had few large corrections towards the Xeriant's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Xeriant, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Xeriant within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.73
β
Beta against Dow Jones-2.1
σ
Overall volatility
0
Ir
Information ratio 0.03

Xeriant Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Xeriant for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Xeriant can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Xeriant is way too risky over 90 days horizon
Xeriant has some characteristics of a very speculative penny stock
Xeriant appears to be risky and price may revert if volatility continues
Xeriant has a very high chance of going through financial distress in the upcoming years
Xeriant currently holds 4.08 M in liabilities with Debt to Equity (D/E) ratio of 0.66, which is about average as compared to similar companies. Xeriant has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Xeriant until it has trouble settling it off, either with new capital or with free cash flow. So, Xeriant's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Xeriant sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Xeriant to invest in growth at high rates of return. When we think about Xeriant's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (13.3 M) with profit before overhead, payroll, taxes, and interest of 0.
Xeriant currently holds about 1.14 M in cash with (6.93 M) of positive cash flow from operations.

Xeriant Fundamentals Growth

Xeriant OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Xeriant, and Xeriant fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xeriant OTC Stock performance.

About Xeriant Performance

By evaluating Xeriant's fundamental ratios, stakeholders can gain valuable insights into Xeriant's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Xeriant has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xeriant has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Xeriant, Inc. operates as an aerospace technology and advanced materials holding company in the United States. Xeriant, Inc. was incorporated in 2009 and is headquartered in Boca Raton, Florida. Xeriant operates under Aerospace Defense classification in the United States and is traded on OTC Exchange.

Things to note about Xeriant performance evaluation

Checking the ongoing alerts about Xeriant for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Xeriant help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Xeriant is way too risky over 90 days horizon
Xeriant has some characteristics of a very speculative penny stock
Xeriant appears to be risky and price may revert if volatility continues
Xeriant has a very high chance of going through financial distress in the upcoming years
Xeriant currently holds 4.08 M in liabilities with Debt to Equity (D/E) ratio of 0.66, which is about average as compared to similar companies. Xeriant has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Xeriant until it has trouble settling it off, either with new capital or with free cash flow. So, Xeriant's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Xeriant sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Xeriant to invest in growth at high rates of return. When we think about Xeriant's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (13.3 M) with profit before overhead, payroll, taxes, and interest of 0.
Xeriant currently holds about 1.14 M in cash with (6.93 M) of positive cash flow from operations.
Evaluating Xeriant's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Xeriant's otc stock performance include:
  • Analyzing Xeriant's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xeriant's stock is overvalued or undervalued compared to its peers.
  • Examining Xeriant's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Xeriant's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xeriant's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Xeriant's otc stock. These opinions can provide insight into Xeriant's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Xeriant's otc stock performance is not an exact science, and many factors can impact Xeriant's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Xeriant OTC Stock analysis

When running Xeriant's price analysis, check to measure Xeriant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeriant is operating at the current time. Most of Xeriant's value examination focuses on studying past and present price action to predict the probability of Xeriant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeriant's price. Additionally, you may evaluate how the addition of Xeriant to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account